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Abstract
Background: Despite its widespread use in pulmonary fibrosis research, the bleomycin mouse model has not
been thoroughly validated from a pulmonary functional standpoint using new technologies. Purpose of this study
was to systematically assess the functional alterations induced in murine lungs by fibrogenic agent bleomycin and
to compare the forced oscillation technique with quasi-static pressure-volume curves in mice following bleomycin
exposure.
Methods: Single intratracheal injections of saline (50 μL) or bleomycin (2 mg/Kg in 50 μL saline) were
administered to C57BL/6 (n = 40) and Balb/c (n = 32) mice. Injury/fibrosis score, tissue volume density (TVD),
collagen content, airway resistance (RN), tissue damping (G) and elastance coefficient (H), hysteresivity (h), and area
of pressure-volume curve (PV-A) were determined after 7 and 21 days (inflammation and fibrosis stage,
respectively). Statistical hypothesis testing was performed using one-way ANOVA with LSD post hoc tests.
Results: Both C57BL/6 and Balb/c mice developed weight loss and lung inflammation after bleomycin. However,
only C57BL/6 mice displayed cachexia and fibrosis, evidenced by increased fibrosis score, TVD, and collagen. At day
7, PV-A increased significantly and G and H non-significantly in bleomycin-exposed C57BL/6 mice compared to
saline controls and further increase in all parameters was documented at day 21. G and H, but not PV-A, correlated
well with the presence of fibrosis based on histology, TVD and collagen. In Balb/c mice, no change in collagen
content, histology score, TVD, H and G was noted following bleomycin exposure, yet PV-A increased significantly
compared to saline controls.
Conclusions: Lung dysfunction in the bleomycin model is more pronounced during the fibrosis stage rather than
the inflammation stage. Forced oscillation mechanics are accurate indicators of experimental bleomycin-induced
lung fibrosis. Quasi-static PV-curves may be more sensitive than forced oscillations at detecting inflammation and
fibrosis.
Background
Pulmonary fibrosis (PF), the progressive destruction of
functional lung parenchyma and its conversion to scar
tissue, can lead to severe decline in lung function, dys-
pnoea and death [1-3]. Among the various methods
available to model PF in laboratory animals, the bleomy-
cin model is the most widely used. Systemic or local
pulmonary administration of bleomycin elicits an initial
inflammatory reaction, followed by fibrosis at later time-
points [4-7]. Despite its extensive use, little is known on
the magnitude and time-course of lung functional
alterations, which take place in this type of injury, owing
partly to the technical difficulty of measuring lung func-
tion in mice. In addition to gaining important pathophy-
siological insight on the effects of collagen deposition in
the lung, precise knowledge of lung function would be
important in order to quantify the severity of physiologi-
cal impairment imposed on the animals, as well as to
measure treatment responses.
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challenging, largely relying on histology and determina-
tion of lung collagen content. Both methods, however,
suffer from limitations, including user-dependency and
stringent technical requirements [4,6-12]. Thus, objec-
tive assessment of lung dysfunction would be of benefit.
Reports of lung function measurements in this model
have yielded conflicting results. Using the technically
challenging and highly invasive alveolar capsule techni-
que in open-chested rats, Dolhnikoff et al.o b s e r v e d
increased lung elastance in bleomycin-exposed animals,
which correlated with collagen content of lung tissue
sections but not with a-smooth muscle actin or elastin
[8]. Conversely, in the study by Goldstein et al., lung
collagen or elastin did not correlate with lung
mechanics, as assessed by quasi-static Pressure-Volume
(PV) curves [13]. Although collagen accumulation and
histologic alterations imply the presence of lung dys-
function, the corresponding mechanical impairment of
the respiratory system, a major determinant of the
severity of the experimental intervention, cannot be pre-
cisely quantified, unless some lung function measure-
ment has been conducted.
Highly sensitive airway pressure transducers developed
during the past fifteen years have enabled objective lung
function determinations on live mice and rats [8,14-16].
The forced-oscillation technique (FOT), a dynamic mea-
surement of lung impedance to airflow, is based on the
observation that lung elastance and airway resistance
vary within the physiological respiratory frequency range
[17,18]. To accurately describe lung mechanical proper-
ties, pulmonary visco-elastic behaviour is assessed over a
range of respiratory frequencies. Using a mathematical
tool known as the constant phase model, lung impe-
dance measurements obtained in the above fashion can
be broken down to components attributable to airway
resistance RN and inertance I in addition to lung tissue
elastance H and tissue damping or energy dissipation G
[17]. With technical advancements, the method became
available for mouse studies and is expected to offer the
greatest degree of accuracy and specificity, not only
since in vivo lung function determinations are carried
out under precise experimental control [8,14,15], but
also since lung mechanical properties are described by a
set of four variables encompassing a wide spectrum of
respiratory frequencies. Using this methodology, Cohen
et al. were able to elucidate previously unrecognized
lung dysfunction in cystic fibrosis trans-membrane con-
ductance regulator-deficient (cftr
-/-) mice, [19] while
other groups have used it to quantify lung pathology in
asthma [20,21]. However, the advantage of the technique
o v e rt h em o r ew i d e l ya v a i l a b l em e a s u r e m e n to fl u n g
compliance using quasi-static PV-curves has not been
experimentally demonstrated. In addition, changes in
lung mechanics after bleomycin delivery to mice are
incompletely understood.
The present study addresses lung structure-function
relationships in the bleomycin model. To this end, we
used two different methodologies to describe the tem-
poral aspects of lung functional derangements and com-
pared these to established biochemical and
morphological indices of lung pathology. To induce
fibrosis, bleomycin was delivered intratracheally (it)t o
C57BL/6 mice, which were sacrificed after seven (early
time-point; predominance of inflammatory changes) or
21 days (late time-point; predominance of fibrotic
changes). Saline-treated C57BL/6 mice as well as Balb/c
mice, which are known for their resistance to bleomycin
[7,22-24], served as negative controls. Lung functional
parameters obtained at both time-points were comple-
mented by biochemical and morphological assays, in
order to characterize the different phases of the model
from a structural and functional perspective.
Methods
Mouse Model
Experiments were conducted according to international
standards [25], and were approved by the by Veterinary
Administration Bureau, Prefecture of Athens, Greece
(Ms. C. Kapetanopoulou and A. Tsigarida, Protocol #K/
3459). Male 8-12 week-old C57BL/6 and Balb/c mice
(Hellenic Pasteur Institute, Athens, Greece) received it
saline (50 μL) or bleomycin (Nippon Kayaku, Tokyo,
Japan; 2 mg/Kg in 50 μL saline), as previously described
[6,26]. Mice were killed by intraperitoneal (ip) pentothal
sodium overdose at early (day 7) or late time-points
(day 21) for determination of lung injury and fibrosis,
respectively. Only a subset of mice was subjected to
lung function measurements prior to sacrifice; this was
done in order to determine whether lung function mea-
surements per se alter biochemical and morphological
readouts of bleomycin-induced lung fibrosis. Thereafter,
the right main stem bronchus was ligated, the right lung
w a sf r o z e ni nl i q u i dN 2 for collagen content measure-
ment and the left lung was inflated with neutral-buf-
f e r e df o r m a l i na t2 0c mH 2O for tissue staining
procedures.
Lung function
Following anaesthesia (75 mg/Kg ip pentothal sodium),
placement of tracheostomy and muscle paralysis (8 mg/
Kg ip succinyl choline), mice were connected to a Flexi-
vent rodent ventilator (Scireq, Montreal, Ontario,
Canada). Prior to measurements, the volume history of
the lung was standardized with two 6-second deep infla-
tions to a pressure limit of 30 cm H2O. After an initial
3-min run-in period of ventilation with FiO2 =0 . 2 1 ,
tidal volume 8 mL/Kg, respiratory rate 150 breaths/min,
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cmH2O, we obtained total respiratory system impedance
by applying an 8-second pseudorandom frequency oscil-
lation (0.5-19.75 Hz) to the airway opening. Measure-
ments were performed 3 times at 30 sec intervals. Data
were fit into the constant phase model in order to frac-
tionate total respiratory input impedance into airways
resistance (RN), tissue damping coefficient (G) and tissue
elastance coefficient (H) [15,27]. Hysteresivity (h)w a s
calculated as the ratio of G to H. The procedure lasted
15 minutes.
To obtain PV curves, the lung was incrementally
inflated to 30 cmH2O and airway pressures were
recorded on each volume increment. Area of PV curve-
(PV-A) was calculated by the Flexivent software and the
slope of the linear portion of the in-and expiratory limb
of the curve was manually calculated.
Histology
Lungs were fixed in formalin (24 hours) and maintained
in 70% ethanol for 3 days, when they were embedded in
paraffin. Five μm-thick sagittal sections were cut and
subsequently stained with Hematoxylin/Eosin and tri-
chrome blue [6]. Ten sequential, non-overlapping fields
(Å = 200) from each lung were evaluated by two blinded
readers (EDM, GTS) for inflammation/injury (0, no
inflammation; 1, focal interstitial infiltrates; 2, diffuse
interstitial infiltrates; 3, focal alveolar infiltrates; 4, con-
fluent alveolar infiltrates/consolidation) and fibrosis (0,
normal lung; 1, thickening of <50% of interalveolar
s e p t a ;2 ,t h i c k e n i n go f≥50% of interalveolar septa; 3,
interalveolar septal thickening with formation of isolated
fibrotic foci; 4, multiple fibrotic foci with distortion of
parenchymal architecture) using 0-4 point scales. Tissue
volume density (TVD), the percentage of lung volume
occupied by tissue, was determined using analysis of ten
sequential, non-overlapping fields (Å = 200) on tissue
sections from each lung by ImageJ freeware (Rasband
1997-2008, available at http://rsb.info.nih.gov/ij. Briefly,
colour digital images were obtained, converted to binary
images, and the percentage of tissue pixels to whole
lung pixels was calculated. We did not measure a refer-
ence volume; instead, we expressed the proportion of
lung volume occupied by tissue as a percentage and not
as an absolute number.
Collagen determination
The Sircol collagen assay (Biocolor, Belfast, Ireland) was
used to measure soluble collagen [28] in whole-lung
protein extracts performed as described elsewhere [6].
Statistical analysis
All values represent mean ± Standard Deviation. One-
way ANOVA with LSD post-hoc tests were used to
compare means. Associations were assessed using Pear-
son’s correlation. All P values are two-tailed; P values <
0.05 were considered significant. P-values less than 0.05
are marked by one asterisk; P-values less than 0.01 by
t w oa s t e r i s k s ,a n dP-values less than 0.001 by three
asterisks. Statistical analyses were done using Statistical
Package for the Social Sciences v.13.0.0 (Chicago, IL)
Results
Body weight in response to bleomycin
We initially sought to recapitulate the reported suscept-
ibility of C57BL/6 mice to pulmonary fibrosis induced
by it bleomycin [4,5,7,22,24-26,29-31] using established
methods. We therefore compared the C57BL/6 strain
against Balb/c mice, known to display minimal lung
fibrosis in response to bleomycin, as well as to mice that
received saline as internal controls. The number and
group allocation of mice utilized for the present studies
are shown in Table 1. Both C57BL/6 and Balb/c mice
developed significant weight loss after it bleomycin, but
not after saline control (Figure 1). In fibrosis-resistant
Balb/c mice, body weight decreased initially, reaching its
nadir one week after injection and recovering by week 2
(Figure 1). In the fibrosis-prone C57BL/6 strain, weight
loss ensued early and recovery did not occur within the
observation period (Figure 1).
Histologic and biochemical indices of inflammation and
fibrosis
The acute inflammatory response to bleomycin was evi-
denced by marked alterations in pulmonary microanat-
omy, including alveolar septal thickening and infiltration
of the parenchyma by inflammatory cells, resulting in
increased lung injury scores (Figures 1, 2), but not in
increased TVD and lung collagen content at day 7 (Fig-
ure 2). This response was of similar magnitude in both
strains. In contrast to Balb/c mice, C57BL/6 mice pro-
ceeded to lung fibrosis development following bleomy-
cin, but not saline (Figures 1, 2). The fibrotic response
of C57BL/6 mice to bleomycin was mirrored by signifi-
cantly increased lung fibrosis score, TVD, and lung col-
lagen content at day 21 (Figure 2). Histologically, the
observed collagen distribution pattern was primarily
bronchocentric, in agreement with previous reports [8].
Table 1 Sample size and group allocations
early harvest
(day 7)
late harvest
(day 21)
C57BL/6 saline 8(4) 8(4)
bleomycin 13(10) 11(7)
Balb/c saline 7(5) 8(8)
bleomycin 8(5) 9(9)
Number, strain and treatment of mice utilized for the present studies, given
as total number (number of mice with lung mechanics measurements).
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fibrosis
We next sought to determine whether measuring lung
function in vivo affects histologic-and collagen-assisted
evaluation of lung fibrosis. To this end, we compared
classic measures of bleomycin-induced lung fibrosis
(fibrosis score of lung tissue sections, TVD, and lung
collagen) between mice that did or did not undergo
lung function testing prior to sacrifice. We found that
pre mortem lung function determinations had no
impact on any of the above parameters. (Table 2).
These results indicate that lung mechanics measure-
ments prior to sacrificing experimental mice do not
alter the results obtained by lung histology and col-
lagen determinations.
Lung functional alterations induced by bleomycin using
forced-oscillation lung mechanics
We subsequently evaluated the time course of lung
mechanical alterations using the constant-phase model
and examined how these correlate with morphological/
biochemical markers of acute inflammation and fibrosis.
We therefore mechanically ventilated the majority of the
mice enrolled in these studies prior to sacrifice (Table
1). Lung function determinations in control and bleomy-
cin-treated C57BL/6 and Balb/c mice lasted roughly fif-
teen minutes per mouse.
In the early inflammatory phase of bleomycin-induced
lung injury (day 7) in C57BL/6 mice, we found modest,
non-significant increases in G and H (Figure 3). Interest-
ingly, in Balb/c mice, despite clear histological evidence
Figure 1 Changes in body mass and lung microstructure after intratracheal bleomycin to a sensitive (C57BL/6) and a resistant (Balb/c)
mouse strain. C57BL/6 (n = 38) and Balb/c (n = 32) mice received single doses of 2 mg/kg intratracheal bleomycin or saline control (injection
volume = 50 μl). A. Both C57BL/6and Balb/c developed early weight loss after bleomycin (but not saline). Only C57BL/6mice displayed persistent
cachexia after bleomycin. B. Representative histologic images of lungs at early (7 days after intratracheal bleomycin), and late (21 days after
intratracheal bleomycin, respectively) time-points. (Scale bar = 200 μm). (***P < .001 compared with C57BL/6 N/S; *P < .05 compared with Balb/c
N/S). Data points, mean; bars, SD. Solid Circles: C57BL/6-Saline; Open circles: Balb/c-saline; Solid triangles: C57BL/6-bleomycin; Open triangles:
Balb/c-bleomycin).
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Page 4 of 13of inflammation, G and H were no different from saline
controls.
On day 21 post-bleomycin, G and H were increased
significantly in the lungs of C57BL/6 mice compared to
saline controls (Figure 3), in temporal relationship to the
development of fibrosis. Notably, the rise in G and H was
more pronounced in the late time point (fibrosis) com-
pared to the early time point. Specifically, G increased by
97% from day 7 to day 21 (p < 0.05) while H rose by 78%
(p < 0.05, Figure, 4). No significant changes were induced
by bleomycin on RNand h on any of the strains.
Lung functional alterations induced by bleomycin using
pressure-volume curves
We undertook a comparison of lung mechanics mea-
sured by FOT to the more traditional method of quasi-
static PV-curves. We specifically looked at the area
enclosed within the PV-curve (PV-A), a measure of lung
hysteresis, in addition to the slope of the in-and expira-
tory limb of the PV-curve. In C57BL/6 mice, bleomycin
led to an upward and leftward shift of the in-and expira-
tory limb of the PV curve as early as day 7; these
changes were associated with increases in PV-A (Figure
4) in addition to the slopes of the in-and expiratory
limb of the PV curve (not shown). PV-A and slopes
increased further at day 21, although to a lesser extent
compared to the rise in G and H. Specifically, PV-A
increased from day 7 to day 21 by 29.3% (Figure 4). Sur-
prisingly, in Balb/c mice, abnormal PV curve morphol-
ogy was noted at day 7, although the increase in PV-A
was non-significant. After 21 days however, PV-A and
slopes increased significantly in the bleomycin group
compared to saline controls and these changes were not
detected by the FOT (Figure 5).
Figure 2 Established parameters of mouse bleomycin-induced lung injury and fibrosis: lung histological score, collagen and tissue
volume density. Mice were treated with bleomycin (black columns) or saline (white columns) as in Fig. 1 and were sacrificed at early and late
time-points. Lungs were sectioned for histologic analyses (left lungs) or homogenized for collagen measurement (right lungs). *P < 0.05, **P <
0.01, and ***P < 0.001 compared with saline-treated controls. Columns, mean; bars, SD. TVD, tissue volume density.
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fibrosis by intratracheal bleomycin
To investigate which of the two different methodologies
tested more clearly describes the morphological and bio-
chemical alterations of the two phases of the bleomycin
model, we correlated values of G, H and PV-A with his-
tological score, lung collagen and TVD in C57/B6 mice
(Figures 6 and 7). To this end, we plotted the values of
G, H and PV-A of each mouse, irrespective of its group
allocation, against the respective values for histological
score, lung collagen and TVD obtained on the same ani-
mal. We observed that H values correlated well with the
presence of fibrosis as determined by the classical para-
meters. In particular, the correlation between H and col-
lagen was the most striking (r = 0.71, p < 0.0001), while
the correlation to histological score and TVD, although
still highly significant, was not as close (r =0 . 5 5a n d
0.52 respectively, Figure 6). Similar correlation data
were obtained for G (r = 0.48 vs. histological score, r =
0.52 vs. TVD and r = 0.68 vs. collagen, p < 0.05 for all
three, not shown).
In contrast to the data obtained for FOT parameters,
PV-A values correlated only poorly with fibrosis indices.
The correlation coefficient r vs. histological score and
TVD was 0.15 and-0.03 respectively (p > 0.05 for both),
whereas PV-A weekly correlated to collagen ratio (r =
0.4, p = 0.04, Figure 8).
Discussion
We undertook a systematic survey of lung mechanical
behaviour in the bleomycin model in order to describe
the time-course of lung functional alterations and estab-
lish relationships between structural and functional para-
meters of lung injury and fibrosis. We used local
pulmonary delivery of bleomycin to sensitive (C57BL/6)
and resistant (Balb/c) mice. Negative controls, which
received saline, were enrolled in each study arm. Pulmon-
ary function determinations using the forced oscillation
technique and PV curve analysis were easy and rapid and
did not compromise subsequent biochemical assays. In
fibrosis-prone C57BL/6 mice, bleomycin exposure led to
an early inflammatory response characterized by a mod-
est increase in lung elastance. The establishment of fibro-
sis led to a further, substantial increase in lung stiffness.
The FOT more specifically detected the presence of
fibrosis, while quasi-static PV-curves were more sensitive
indicators of lung dysfunction in global terms, yielding
pathological values in C57BL/6 mice at the early (inflam-
mation) time-point as well as in Balb/c mice.
Pulmonary fibrosis, regardless of whether idiopathic or
occurring in the setting of systemic disease [1], leads to
destruction of lung architecture and lung functional
decline. Among the various predictors of outcome stu-
died, serial lung function testing is so far the most use-
ful predictor of death [32]. It would thus appear that,
for a bleomycin experiment to adequately model human
fibrosis, some degree of functional impairment should
be present. Yet few studies have investigated functional
alterations in response to bleomycin in mice [9,33-35]
and only a small minority of bleomycin studies report
lung function results, possibly due to the required tech-
nical expertise and cost. Thus, despite their substantial
drawbacks lung histology and collagen content determi-
nations remain the established means of assessing bleo-
mycin-induced dysfunction. Histological measurements
are not only subject to observer bias and sampling
errors, but also require the application of expensive
and/or time-consuming processing, such as morphome-
try [36]. Collagen measurement, the gold standard for
evaluating murine lung fibrosis, does not give spatial
information [37] and, so far, has not been clearly shown
to correlate with lung mechanics [4,8,13]. In addition,
the amount of collagen may not be the sole determinant
of lung mechanical properties; rather, the spatial organi-
zation of collagen fibres and the degree of cross-linkage
as well as connections to other matrix components may
be critical [38,39]. Importantly, treatment interventions
m a yh a v eap o s i t i v ei m p a c to nl u n gd y s f u n c t i o ni nt h e
bleomycin model without changing collagen content or
histology [9]. Finally, even if collagen deposition and his-
tological alterations consistent with fibrosis can be
detected, their functional importance cannot be assessed
without lung function testing.
The FOT is gradually emerging as an objective and
detailed means of assessing lung function in normal and
diseased lungs. Because lung tissue elastance and airway
resistance vary with respiratory rate [27], measuring fre-
quency-dependent total lung impedance and breaking it
down to its resistive and elastic components may pro-
vide physiological information, which would be missed
Table 2 Established end-points of bleomycin-induced
lung injury and fibrosis in mice that did or did not
undergo lung function measurements.
day 7 day 21
C57BL/6 Balb/c C57BL/6 Balb/c
no lung function measurements performed
n 3340
lung injury score 2.8 ± .5 3.0 ± .0 3.8 ± .8 -
TVD (%) 30.5 ± .2 26.5 ± 7.4 30.3 ± 3.4 -
lung collagen (μg) 205 ± 99 185 ± 92 320 ± 230 -
lung function measurements performed
n 8579
lung injury score 2.8 ± 1.7 3.4 ± 0.4 3.6 ± .5 1.3 ± 1.5
TVD (%) 29.5 ± 9.6 23.7 ± 6.5 31.5 ± 3.4 24.3 ± 6.3
lung collagen (μg) 211 ± 102 177 ± 101 325 ± 312 179 ± 69
Data are presented as mean ± SD. No significant differences were observed.
TVD: Tissue volume density.
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fitting frequency-dependent lung impedance data into
the constant-phase model, lung mechanical properties
can be described using four parameters: airway resis-
tance RN, inertance I,l u n gt i s s u ee n e r g yd i s s i p a t i o nG,
and lung elastance H [14]. This approach has provided
valuable insights in the pathophysiology of pulmonary
functional impairment in various experimental models.
For example, using FOT it was possible to show that
the mechanism of exaggerated metacholin response in
ovalbumin-challenged mice is primarily due to airway
closure rather that smooth muscle contraction [41].
However, the utility of this methodology in the bleomy-
cin model is less clear, since the studies so far have not
described the temporal evolution of lung (dys)function
in the model, nor have they examined the correlation of
individual lung function parameters to morphological
and biochemical indices. In addition, despite its theoreti-
cal advantages compared to classical PV-curves, which
can be obtained with a variety of rodent ventilators, its
superiority over the existing method has not been
demonstrated experimentally in a manner convincing
enough to justify the added cost. To address some of
these issues, our study compared both methods to the
biochemical and histological fibrosis indices of the bleo-
mycin model.
In the early stages following bleomycin administration,
we found, as expected, histological evidence of acute
Figure 3 Mechanical parameters of lung injury and fibrosis induced by bleomycin administration to resistant (Balb/c) and sensitive
(C57BL/6) mouse strains. Mice were treated with bleomycin (black columns) or saline (white columns) as in Fig. 1 and lung function was
determined using the forced oscillation technique and the constant phase model at early and late time-points. *P < 0.05, **P < 0.01, and ***P <
0.001 compared with saline-treated controls. Columns, mean; bars, SD. RN, airway resistance; H, lung tissue elastance; G, lung tissue damping; h,
hysteresivity.
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changes in lung function, depending on the methodol-
ogy used and the strain. In C57BL/6 mice, despite clear
trends toward increased H and G by the FOT, statistical
significance was not reached, possibly due to limited
sample size. When lung mechanics were assessed using
PV curves, however, the increase in PV-A was in fact
statistically significant, implying that this method may
have an advantage over the FOT in terms of sensitivity.
At later time-points, inflammation is succeeded by fibro-
sis in the lungs of bleomycin-susceptible mice. Lung
matrix expansion gradually leads to bridging of increas-
ingly large areas of the lung with collagen fibres; beyond
a certain threshold, a sharp rise in lung stiffness is
thought to occur [38,39]. In functional terms, this pro-
cess is expressed as a dramatic rise predominantly in G,
H and to a lesser extent in PV-A. The observed correla-
tion of G and H with fibrosis scores indicates that these
functional perturbations are likely explained by the pre-
sence of matrix remodelling, with collagen deposition as
its major feature. Intuitively, the rise in H could be
attributed to increased tension in the alveolar walls dur-
ing mechanical deformation, in conjunction with
reduction of lung volume due to fibrosis. In the absence
of lung volume measurements, the relative importance
of these two factors cannot be quantified. The rise in G
is less intuitive. Even though G reportedly represents
inhomogeneity in airflow within the peripheral lung and
has also been associated with increased peripheral air-
way resistance, [41] its meaning remains somewhat
obscure [42] and G values are less frequently reported.
In these studies, the increase in G may represent the tis-
sue inhomogeneity inherent to fibrosis development.
The ratio G/H, known as hysteresivity, was aimed at
improving on some of the shortcomings of H or G
alone. However, in these experiments due to the propor-
tionate increase of G and H, hysteresivity did not change
in any of the groups.
Lung mechanics assessment using quasi-static PV-
curves yielded, to some extent, similar results with the
data obtained by the FOT. PV-A increased significantly at
the early time-point in C57/B6 mice and a further increase
was recorded at the late time-point. However, this increase
was of a lesser magnitude compared to the FOT data.
Thus, correlation with fibrosis indices was weak at best
but mostly absent. Taken together, these data indicate that
Figure 4 Pressure-Volume curves in C57BL/6 mice. Sample Pressure-Volume curves obtained 7 days (A) and 21 days (B) after intratracheal
bleomycin (black squares) or saline (grey triangles) to C57BL/6 mice. Cumulative results of PV-curve area for early and late time-points.(C). *P <
0.05, **P < 0.01, and ***P < 0.001 compared with saline-treated controls. Columns, mean; bars, SD.
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t h ep r e s e n c eo ff i b r o s i si nt h em o u s el u n g ,w h e r e a st h e
PV-curve, although sensitive at recording lung dysfunc-
tion, may not allow the differentiation between the cause i.
e. inflammation/edema vs. fibrosis.
The difference in susceptibility of C57B/6 and Balb/c
mice to bleomycin-induced fibrosis is established in the
literature [4,5,7,22-25,29,30,36] and thus Balb/c mice
served as internal controls for sensitive C57B/6 mice.
Studies comparing responses of these two strains to
bleomycin report differences in gene expression [7],
BAL cytokine profile [43] and ability for tissue repair
[7]. Specifically, fibrosis-prone C57BL6 mice tend to
have increased vascular protein leak [7], proteolytic
enzyme activity [7], pro-inflammatory cytokine levels
(MCP-1, TNF-a, IL-6) [7,43], TGF-b receptors [43], and
apoptosis indices (caspase-8 and-9 activity). With
respect to gene expression profile, Pottier et al. con-
ducted a microarray analysis and found a set of 25
genes differentially expressed between the two strains,
many of which were related to inflammatory response
and tissue repair [7].
Predictably, the Balb/c strain did not develop fibrosis
in response to bleomycin and had normal lung function
by FOT. This finding may seem to contradict a recently
published study reporting increases in H in bleomycin-
exposed Balb/c mice [34]. However, in this paper a dif-
ferent protocol was used to induce lung fibrosis, since,
in addition to bleomycin, intraperitoneal cyclophospha-
mide was also administered. Since collagen values are
not reported in this study, it is not possible to interpret
this discrepancy in findings. A surprising finding in our
dataset, however, was that PV-A and slopes were signifi-
cantly higher in bleomycin-compared to saline groups,
indicating that despite lack of evidence for collagen
accumulation, subtle mechanical changes take place in
this strain as well. Furthermore, even though Balb/c
mice developed similar degree of inflammation at the
early time point as C57B/6 mice by morphological cri-
teria, this was not reflected in lung function indices, for
reasons yet to be determined.
One point of controversy regarding invasive lung func-
tion measurements in mice is whether these measure-
ments should be performed in the presence or absence of
PEEP. Use of PEEP helps to prevent alveolar collapse and
reduction in lung volume during mechanical ventilation.
However, we reasoned that this is more likely to occur in
the presence of lung damage, including acute lung injury.
Figure 5 Pressure-Volume curves in Balb/c mice. Sample Pressure-Volume curves obtained 7 days (A)a n d2 1d a y s( B)a f t e ri n t r a t r a c h e a l
bleomycin (black squares) or saline (gray triangles) to Balb/c mice. Cumulative results of PV-curve area for early and late time-points (C). *P <
0.05 compared with saline-treated controls. Columns, mean; bars, SD.
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maintain stable values for H and G for several minutes,
this is not the case with mice subjected to insults injur-
ious to the lung. Therefore, avoiding PEEP may help
unmask subtle functional abnormalities, which may be
missed if PEEP is applied.
Our findings in bleomycin-treated mice are similar to
the ones observed in humans with end-stage fibrotic
lung disease. Published data from mechanically venti-
lated humans with end-stage fibrosis demonstrate that
the disease is characterized by extensive scarring and
reorganization of lung architecture, resulting in dimin-
ished lung volumes [44]. With loss of lung volume, the
pressure-volume curve of the lung becomes contracted
on its volume axis, thus reducing static and dynamic
compliance. In this regard, the findings of the present
study are in line with data from human subjects, a fact
further validating the intratracheal bleomycin mouse
model of lung fibrosis as an analogue to the human
disease.
Although in our hands murine lung function measure-
ments proved valuable indicators of bleomycin-induced
lung fibrosis, some shortcomings of the present work
and the method need to be pointed out. Firstly, procur-
ing the equipment requires a financial investment. Sec-
ondly, we did not study lung function in other models
of pulmonary fibrosis (eg, using silica or in genetic mod-
els), to further expand the possible uses of the method.
Thirdly, it may be problematic to adjust tidal volume to
body weight in the presence of fibrosis-induced weight
loss, but this issue has not been resolved experimentally
to our knowledge. Tidal volume in diseased animals
may depend on a variety of factors, including functional
dead space and carbon dioxide production, which are
difficult to quantify in experimental mice. Thus, pending
further experimental evidence, adjusting ventilation to
body weight may currently be a reasonable option. And
finally, since functional residual capacity was not mea-
sured in our study, some of the mechanical alterations
observed following bleomycin challenge may be related
to loss of lung volume, which would be expected in the
presence of both acute lung injury and fibrosis.
The present work demonstrates that functional decline
in the course of bleomycin injury is time-dependent and
Figure 6 Correlation of lung elastance by forced oscillation method with morphological and biochemical indices in the bleomycin
mouse model. Correlation of lung elastance H with histology score, tissue volume density (TVD) and lung collagen in all C57BL/6mice
irrespective of group allocation. r = correlation coefficient.
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greater extent than inflammation. We further show that
for a more accurate assessment of lung function in
rodent lung pathology models, complementary meth-
odologies may be more informative than individual
ones. Therefore, lung function measurements may serve
as a valuable adjunct to pulmonary fibrosis research.
Recent reports strongly advocate in favour of re-evaluat-
ing traditional histologic and biochemical tools for
quantifying pulmonary fibrosis, since human trials for
pulmonary fibrosis mostly use lung function parameters
[1,25]. Based on our results, oscillatory measures of ela-
stance and tissue damping are sensitive and reliable sur-
rogates of fibrotic injury following bleomycin at later
time-points, when fibrotic remodeling has had sufficient
time to develop. These parameters reflect whole-lung
visco-elastic behaviour and could serve as novel, user-
independent end-points of lung fibrosis in future studies
using this model.
Conclusions
-Lung damage due to intratracheal administration of bleo-
mycin can be divided into two stages, the inflammation
stage and the fibrosis stage, with distinct functional pro-
files, at least when the forced oscillation technique is used.
-Lung elastance measured by the forced oscillation
technique strongly correlates with soluble collagen con-
tent in lungs and histological indices of lung pathology.
-Quasi-static Pressure-Volume curves of the respira-
tory system sensitively detect lung dysfunction in the
bleomycin model but seem to be less specific for
fibrosis.
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